BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Numico G, Franco P, Cristofano A, Migliaccio F, Spinazzé S, Silvestris N, Cante D, Sciacero P, La Porta MR, Girelli F, Ricardi U. Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidence. Crit Rev Oncol Hematol 2013;85:112-20. [PMID: 22743346 DOI: 10.1016/j.critrevonc.2012.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Vesci L, Carollo V, Rosi A, De Santis R. Therapeutic efficacy of intra-tumor AvidinOX and low systemic dose biotinylated cetuximab, with and without cisplatin, in an orthotopic model of head and neck cancer. Oncol Lett 2019;17:3529-36. [PMID: 30867794 DOI: 10.3892/ol.2019.10003] [Reference Citation Analysis]
2 Bossi P, Locati L, Licitra L. Emerging tyrosine kinase inhibitors for head and neck cancer. Expert Opinion on Emerging Drugs 2013;18:445-59. [DOI: 10.1517/14728214.2013.842976] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 Magrini SM, Buglione M, Corvò R, Pirtoli L, Paiar F, Ponticelli P, Petrucci A, Bacigalupo A, Crociani M, Lastrucci L, Vecchio S, Bonomo P, Pasinetti N, Triggiani L, Cavagnini R, Costa L, Tonoli S, Maddalo M, Grisanti S. Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial. J Clin Oncol 2016;34:427-35. [PMID: 26644536 DOI: 10.1200/JCO.2015.63.1671] [Cited by in Crossref: 142] [Cited by in F6Publishing: 55] [Article Influence: 20.3] [Reference Citation Analysis]
4 Taberna M, Oliva M, Mesía R. Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Front Oncol 2019;9:383. [PMID: 31165040 DOI: 10.3389/fonc.2019.00383] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
5 Franco P, Potenza I, Moretto F, Segantin M, Grosso M, Lombardo A, Taricco D, Vallario P, Filippi AR, Rampino M, Ricardi U. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study. Radiat Oncol 2014;9:297. [PMID: 25544371 DOI: 10.1186/s13014-014-0297-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
6 Franco P, Martini S, Di Muzio J, Cavallin C, Arcadipane F, Rampino M, Ostellino O, Pecorari G, Garzino Demo P, Fasolis M, Airoldi M, Ricardi U. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-0950-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
7 Courthod G, Franco P, Palermo L, Pisconti S, Numico G. The role of microRNA in head and neck cancer: current knowledge and perspectives. Molecules 2014;19:5704-16. [PMID: 24802984 DOI: 10.3390/molecules19055704] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
8 Lionello M, Lovato A, Staffieri A, Blandamura S, Turato C, Giacomelli L, Staffieri C, Marioni G. The EGFR-mTOR pathway and laryngeal cancer angiogenesis. Eur Arch Otorhinolaryngol. 2014;271:757-764. [PMID: 24065188 DOI: 10.1007/s00405-013-2691-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
9 Franco P, Fiorentino A, Dionisi F, Fiore M, Chiesa S, Vagge S, Cellini F, Caravatta L, Tombolini M, De Rose F, Meattini I, Mortellaro G, Apicella G, Marino L, Greto D. Combined Modality Therapy for Thoracic and head and Neck Cancers: A Review of Updated Literature Based on a Consensus Meeting. Tumori 2016;102:459-71. [DOI: 10.5301/tj.5000525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Vesci L, Milazzo FM, Anastasi AM, Petronzelli F, Chiapparino C, Carollo V, Roscilli G, Marra E, Luberto L, Aurisicchio L, Pacello ML, Spagnoli LG, De Santis R. Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer. Oncotarget 2016;7:914-28. [PMID: 26575422 DOI: 10.18632/oncotarget.6089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
11 Eid A, Li S, Garza R, Wong ME. Chemotherapy for oral and maxillofacial tumors: an update. Oral Maxillofac Surg Clin North Am 2014;26:163-9. [PMID: 24794265 DOI: 10.1016/j.coms.2014.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Wilson GD, Thibodeau BJ, Fortier LE, Pruetz BL, Galoforo S, Akervall J, Marples B, Huang J. Gene expression changes during repopulation in a head and neck cancer xenograft. Radiother Oncol 2014;113:139-45. [PMID: 25245558 DOI: 10.1016/j.radonc.2014.08.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Franco P, Rampino M, Ostellino O, Schena M, Pecorari G, Garzino Demo P, Fasolis M, Arcadipane F, Martini S, Cavallin C, Airoldi M, Ricardi U. Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-0886-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]